EpiVacCorona Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04780035Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
NCT05021016Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above